Business Description
Pet Pharm Biotech Co Ltd
ISIN : TW0007762007
Description
Pet Pharm Biotech Co Ltd is a Pharmaceutical company. The company is engaged in manufacturing medicinal products and medicine drugs. The products offered by the company include FDG Fluodeoxyglucose Injection (18F-FDG), Naolixi Injection (18F-FBB), Sodium fluoride injection (18F-NaF), and others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.14 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | 5.67 | |||||
| Interest Coverage | 23.43 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.24 | |||||
| 9-Day RSI | 48.05 | |||||
| 14-Day RSI | 50.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.68 | |||||
| Quick Ratio | 2.62 | |||||
| Cash Ratio | 2.34 | |||||
| Days Inventory | 66.58 | |||||
| Days Sales Outstanding | 96.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.54 | |||||
| Forward Dividend Yield % | 0.54 | |||||
| 5-Year Yield-on-Cost % | 0.54 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.21 | |||||
| Operating Margin % | 3.8 | |||||
| Net Margin % | 6.32 | |||||
| FCF Margin % | -128.36 | |||||
| ROE % | 1.7 | |||||
| ROA % | 1.33 | |||||
| ROIC % | 1.6 | |||||
| ROC (Joel Greenblatt) % | 3.79 | |||||
| ROCE % | 1.6 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 168.18 | |||||
| PE Ratio without NRI | 168.18 | |||||
| PS Ratio | 10.64 | |||||
| PB Ratio | 2.99 | |||||
| Price-to-Tangible-Book | 3.06 | |||||
| Price-to-Operating-Cash-Flow | 57.45 | |||||
| EV-to-EBIT | 169.72 | |||||
| EV-to-EBITDA | 50.96 | |||||
| EV-to-Revenue | 11 | |||||
| EV-to-FCF | -8.57 | |||||
| Price-to-Graham-Number | 4.78 | |||||
| Price-to-Net-Current-Asset-Value | 7.74 | |||||
| Price-to-Net-Cash | 10.25 | |||||
| Earnings Yield (Greenblatt) % | 0.59 | |||||
| FCF Yield % | -10.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pet Pharm Biotech Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 120.95 | ||
| EPS (TTM) (NT$) | 0.22 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 50.66 | ||
| 14-Day ATR (NT$) | 1.107319 | ||
| 20-Day SMA (NT$) | 37.2575 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 27.5 - 42.2 | ||
| Shares Outstanding (Mil) | 40.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pet Pharm Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pet Pharm Biotech Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pet Pharm Biotech Co Ltd Frequently Asked Questions
What is Pet Pharm Biotech Co Ltd(ROCO:7762)'s stock price today?
The current price of ROCO:7762 is NT$37.00. The 52 week high of ROCO:7762 is NT$42.20 and 52 week low is NT$27.50.
When is next earnings date of Pet Pharm Biotech Co Ltd(ROCO:7762)?
The next earnings date of Pet Pharm Biotech Co Ltd(ROCO:7762) is .
Does Pet Pharm Biotech Co Ltd(ROCO:7762) pay dividends? If so, how much?
The Dividend Yield %  of Pet Pharm Biotech Co Ltd(ROCO:7762) is 0.54% (As of Today), Highest Dividend Payout Ratio of Pet Pharm Biotech Co Ltd(ROCO:7762) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Pet Pharm Biotech Co Ltd(ROCO:7762) is 0.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers